UBS Group’s Minerva Surgical UTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-2,093
Closed -$10.7K – 10231
2023
Q2
$10.7K Buy
+2,093
New +$10.2K ﹤0.01% 7125
2023
Q1
– Sell
-2,010
Closed -$8.84K – 11036
2022
Q4
$8.84K Buy
+2,010
New +$13.3K ﹤0.01% 8719
2022
Q2
– Sell
-54
Closed -$5K – 11319
2022
Q1
$5K Sell
54
-182
-77% -$18.5K ﹤0.01% 9208
2021
Q4
$24K Buy
+236
New +$33.6K ﹤0.01% 7654

Other funds holding UTRS

UBS Group's UTRS Position: Q3 2023 in Review

UBS Group sold out of Minerva Surgical (UTRS) in Q3 2023, closing a stake of 2,093 shares — an estimated $10.7K sold.

UBS Group first reported a position in UTRS in Q4 2021 and held it in 4 quarters. The position peaked at $24K in Q4 2021. 13 funds tracked by Wall St. Rank hold UTRS as of Q3 2023.

  • UBS Group reported no remaining Minerva Surgical position as of Q3 2023 after selling out during the quarter.
  • UBS Group sold 2,093 Minerva Surgical shares in Q3 2023, an estimated $10.7K.
  • UBS Group first reported a position in Minerva Surgical in Q4 2021 and held it in 4 quarters.
  • UBS Group's Minerva Surgical position peaked at $24K in Q4 2021.
  • 13 funds tracked by Wall St. Rank held Minerva Surgical as of Q3 2023.

Based on UBS Group's 13F filing for Q3 2023, filed 9 Nov 2023.